INIS
diseases
100%
patients
74%
lungs
63%
children
54%
asthma
39%
fibrosis
36%
symptoms
33%
volume
30%
interventions
28%
risks
25%
reduction
20%
levels
19%
quality of life
17%
inflammation
15%
values
15%
control
14%
data
13%
glucocorticoids
13%
comparative evaluations
12%
covid-19
12%
detection
12%
air
12%
humans
12%
mortality
12%
impedance
11%
air flow
10%
breath
10%
in vitro
9%
netherlands
9%
dusts
9%
Keyphrases
Chronic Obstructive Pulmonary Disease
62%
Cystic Fibrosis
31%
Lung Function
30%
Asthma
28%
Forced Expiratory Volume in 1 Second (FEV1)
28%
Smokers
22%
Pulmonary Exacerbation
21%
Spirometry
21%
Smoking Cessation
17%
COVID-19
13%
Bronchoscopic Lung Volume Reduction
13%
Chronic Obstructive Pulmonary Disease Patient
13%
Netherlands
12%
Health-related Quality of Life
12%
Respiratory Symptoms
12%
Early Detection
12%
Dyspnea
11%
Maastricht
10%
Asthma Patients
10%
Quality of Life
9%
Impedance Measurement
9%
Home Monitoring
9%
Glucocorticoid Receptor
9%
Immune Function
9%
Real Solutions
9%
Post-bronchodilator
9%
Confidence Interval
8%
Moderate to Severe
8%
Multifaceted Intervention
8%
Bronchial Epithelial Cells
8%
Medicine and Dentistry
Chronic Obstructive Pulmonary Disease
32%
Cystic Fibrosis
27%
Symptom
25%
Asthma
15%
Forced Expiratory Volume
15%
Prevalence
14%
Dyspnea
14%
Lung Volume
13%
COVID-19
12%
Spirometry
11%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Observational Study
9%
Smoking
9%
Home Monitoring
9%
Volatile Organic Compound
7%
Nicotine Withdrawal
6%
Disease Exacerbation
6%
Infection
6%
Silo-Filler's Disease
6%
Bronchodilating Agent
6%
Quality of Life
5%
Obstructive Lung Disease
5%